Federal Circuit Reluctantly Applies Mayo and Denies Petition for Rehearing en banc in Medical Diagnostic Case

Feb 11, 2016

Reading Time : 1 min

By: Michael P. Kahn, Matt Weiss, Law Clerk (not admitted to practice)

Judges Lourie and Dyk each wrote concurring opinions that agreed with the court application of the Mayo framework but proposed alternative approaches to preserve the patentability of such valuable work–including possible further refinement of the standard by the Supreme Court. For example, Judge Lourie wrote, “[t]he claim to this invention…might have been better drafted as a…Jepson claim, which recites what is in the prior art and what is the improvement.” Judge Dyk expressed concern that “there is a problem with Mayo insofar as it concludes that inventive concept cannot come from discovering something new in nature.” He proposed “allowing narrow claims that have been actually reduced to practice when those claims embody an inventive, newly discovered law of nature…” and asserted that a “future case is likely to present a patent claim where the inventive concept resides in a newly discovered law of nature or natural phenomenon, but the claim is narrowly drawn and actually reduced to practice.” Such a claim, he suggested, may allow “the Supreme Court…an opportunity to revisit the Mayo/Alice framework in this one limited aspect.”

Ariosa Diagnostics, Inc. v. Sequenom, Inc., 2015 U.S. App. LEXIS 20842 (Fed. Cir. Dec. 2, 2015) (en banc).

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.